Clinical Trial Update: A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating EndoTAG-1 in patients with hepatic metastases completed, focusing on pharmacokinetics and mode of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Liver Metastases

Drugs mentioned

• EndoTAG-1

Snippet

Sponsor: MediGene | Conditions: Liver Cancer, Neoplasm Metastasis | Phase 2 | Status: COMPLETED